4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-25-000002
Chief Financial Officer returned 258 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Carter Robert Ross Chief Financial Officer | 2025-01-06 | Returned to the company | −258 | $0.34 | $86 | 31,501 | D |
Loading xslF345X05/wk-form4_1736273886.xml…